BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
89.27
-0.04 (-0.04%)
At close: Mar 20, 2026, 4:00 PM EDT
90.93
+1.66 (1.86%)
After-hours: Mar 20, 2026, 7:32 PM EDT
BioNTech SE Stock Forecast
Stock Price Forecast
The 13 analysts that cover BioNTech SE stock have a consensus rating of "Strong Buy" and an average price target of $134.15, which forecasts a 50.27% increase in the stock price over the next year. The lowest target is $94 and the highest is $171.
Price Target: $134.15 (+50.27%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 6 | 6 | 7 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 11 | 11 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $134 → $125 | Buy | Maintains | $134 → $125 | +40.02% | Mar 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 | Strong Buy | Maintains | $171 | +91.55% | Mar 11, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $145 → $130 | Strong Buy | Maintains | $145 → $130 | +45.63% | Mar 11, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $116 → $94 | Hold | Maintains | $116 → $94 | +5.30% | Mar 11, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $143 → $128 | Buy | Maintains | $143 → $128 | +43.39% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
2.29B
from 2.87B
Decreased by -20.14%
Revenue Next Year
2.40B
from 2.29B
Increased by 4.76%
EPS This Year
-3.53
from -4.70
EPS Next Year
-3.35
from -3.53
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.0B | 3.4B | |||
| Avg | 2.3B | 2.4B | |||
| Low | 2.0B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.4% | 50.3% | |||
| Avg | -20.1% | 4.8% | |||
| Low | -31.6% | -38.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.78 | -0.39 | |||
| Avg | -3.53 | -3.35 | |||
| Low | -10.42 | -12.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.